Striatal dopamine and homovanillic acid in Huntington's Disease

Keywords

Homovanillic acid, Putamen, Caudate nucleus, Dopamine, Huntington's disease

References

• Huntington's ChoreaT. Caraceni, F. Girotti — 1977
• An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.Ernest G. Spokes — 1979
• A FURTHER STUDY OF THE DISTRIBUTION OF γ‐AMINOBUTYRIC ACID BETWEEN EXCITATORY AND INHIBITORY AXONS OF THE LOBSTERE. A. Kravitz, Dave Potter — 1965
• Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neuronsEldad Melamed, Franz Hefti, Edward D. Bird — 1982
• Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.Thomas L. Perry, Shirley Hansen, Marlene Kloster — 1973
• Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical FindingsT.J. Crow, H. F. Baker, A.J. Cross — 1979
• Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.Edward D. Bird, L L Iversen — 1974
• Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.E.G. Spokes — 1980
• CSF homovanillic acid: an index of dopaminergic activity.G. Curzon — 1975
• Neurotransmitter Enzymes and Receptors in Post-mortem Brain in Schizophrenia: Evidence that an Increase in D2 Dopamine Receptors is Associated with the Type I SyndromeT. Crow, F. Owen, A. Cross — 1981

Cited by

• Untersuchung des Expressionsmusters und der Neuropathologie konditionaler Mausmodelle des Morbus ParkinsonSilke Nuber — 2008
• GENETICS AND NEUROPATHOLOGY OF HUNTINGTON’S DISEASEAnton Reiner, Ioannis Dragatsis, Paula Dietrich — 2011
• Pallidal GABA and chorea in Huntington's diseaseSally J. Pearson, K. W. G. Heathfield, Gavin P. Reynolds — 2005
• Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manM. Gerlach, Peter Riederer — 2005
• HPLC analysis of somatostatin related peptides in putamen of Huntington's Disease patientsGünther Sperk, Gavin P. Reynolds, Peter Riederer — 2005
• Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology.George J. Yohrling, George C.‐T. Jiang, Molly M. DeJohn — 2003
• Neocortical neurotransmitter markers in Huntington's diseaseSally J. Pearson, Gavin P. Reynolds — 2005
• Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasetsRobert B. Laprairie, Amina M. Bagher, Sophie V. Precious — 2015
• Plasma Homovanillic Acid and Prolactin in Huntington’s DiseaseManolis Markianos, Μάριος Πάνας, Nikos Kalfakis — 2009
• Error Processing in Huntington's DiseaseChristian Beste, Carsten Saft, Jürgen Andrich — 2006
• Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseasesP. Dostert, M. Strolin Benedetti, G Dordain — 2005
• Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo EvidenceUlrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener‐Schmid — 2007
• Basal ganglia function in genetic mouse models of Huntington's disease: a circuit-level approachJoshua W. Callahan — 2013
• Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemiaEFSA Panel on Plant Protection Products and their residues (PPR), Colin Ockleford, Paulien Adriaanse — 2017
• Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus NeurotoxicityRyoma Morigaki, Satoshi Goto — 2017
• Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic SystemHikaru Takeuchi, Ryuta Kawashima — 2018
• Huntington’s disease: the coming of ageMritunjay Pandey, Usha Rajamma — 2018
• Unravelling the behavioural and molecular hallmarks of Spinocerebellar Ataxia type 17 (SCA17). Studies on a transgenic rat modelElisavet I. Kyriakou, Elisavet I. Kyriakou, J. Harst — 2020
• Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington’s Disease Status Based on Omics DataChristiana Christodoulou, Margarita Zachariou, Marios Tomazou — 2020
• Distinct Roles of Honeybee Gut Bacteria on Host Metabolism and Neurological ProcessesZijing Zhang, Xiaohuan Mu, Yao Shi — 2022

Related papers

• [MRI scan of striatum volume in healthy adults].Jingfeng Xu, Xiaojun Xu, Qidong Wang — 2010
• Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.E. Melamed, Franz Hefti, R. J. Wurtman — 1980
• The influence of 1-hydroxy-3-amino pyrrolidinone-2 (HA-966) on dopamine metabolism in the corpus striatum.F. C. Hillen, E. L. Noach — 1971
• Homovanillic acid and dihydroxyphenylacetic acid in the striatum of monkeys with brain lesions.D.F. Sharman, L.J. Poirier, Gérard F. Murphy — 1967
• CSF dopamine increased in depression: CSF dopamine, noradrenaline and their metabolites in depressed patients and in controls.Annette Gjerris — 1987
• Diffusion-Weighted MRI Findings of Caudate Nucleus and Putamen in Patients With Obsessive-Compulsive DisorderSerpil AĞLAMIŞ, Ayşe Murat Aydın, Yeşim Eroğlu — 2021
• An immunohistochemical investigation of the human neostriatum in huntington's diseaseSatoshi Goto, Asao Hirano, R. R. Rojas-Corona — 1989
• 99Tc(上标 m)-TRODAT-1脑显像在帕金森病诊断与分级中的应用董峰, 刘晓华, 谭建 — 2006